Stockreport

Invivyd (IVVD) Is Up 48.3% After Strong Q3 Financials and FDA Trial Clearance for VYD2311 – Has the Bull Case Changed? [Yahoo! Finance]

Invivyd, Inc.  (IVVD) 
PDF loss significantly reduced to US$10.47 million from US$60.74 million, alongside FDA clearance to begin pivotal trials for its VYD2311 antibody candidate. The combinati [Read more]